A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants
PHASE1CompletedINTERVENTIONAL
Enrollment
100
Participants
Timeline
Start Date
January 26, 2020
Primary Completion Date
December 23, 2020
Study Completion Date
January 31, 2021
Conditions
Healthy
Interventions
DRUG
TLL018 tablet, placebo
Oral QD
Trial Locations (1)
07094
Frontage Clinical Services, Inc., Secaucus
All Listed Sponsors
lead
TLL Pharmaceutical, LLC
INDUSTRY
NCT04243083 - A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants | Biotech Hunter | Biotech Hunter